New screening test detects counterfeit fentanyl patches in pharmacies, indicating a solution for diversion and abuse.
Objectives: Absence of a rapid screening test for detecting counterfeit fentanyl patches at point of care is facilitating in diversion and abuse of transdermal fentanyl. Our recent research project has made this test available and accessible to community pharmacists.
No takes yet. Share an insight, caveat, or question.
Andrew Rey-McIntyre (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: